SNORD114-16: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD114-16

NCBI ID: G767594

Other Name(s): small nucleolar RNA, C/D box 114-16 | Small nucleolar RNA, C/D box 114-16 | 14q(II-16)

SNORD114-16: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression in eukaryotic cells. One of the key functional groups of snRNA is the C/D box, which is a region of the RNA molecule that contains a specific sequence of nucleotides. C/D box snRNA molecules are highly conserved across different species and are involved in various cellular processes, including DNA replication, transcription, and translation.

One of the most well-known C/D box snRNA molecules is SNORD114-16. This RNA molecule has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the properties of SNORD114-16, its potential drug target status, and its potential as a biomarker for disease diagnosis and treatment.

Properties of SNORD114-16

SNORD114-16 is a 22-nt RNA molecule that contains a single exon. It has a calculated molecular weight of 18.8 kDa and a base composition of A=29, C=50, G=21, and U=4. The RNA molecule has a single RNA secondary structure, which is a hairpin loop.

The C/D box region of SNORD114-16 is a 12-nt sequence that contains the conserved C/D box motif. This motif consists of a specific core sequence of GAGCG, which is followed by a series of secondary motifs that include a 5'-terminal alpha-helix, a 3'-terminal beta-sheet, and a 2'-terminal loop. The C/D box region of SNORD114-16 is conserved across different species, and its presence suggests that it plays a critical role in the regulation of gene expression.

Potential Drug Target Status

SNORD114-16 has been identified as a potential drug target due to its unique C/D box structure and its involvement in various cellular processes. The C/D box region of SNORD114-16 is involved in the regulation of gene expression, and studies have shown that it plays a role in the development and progression of various diseases.

One of the potential mechanisms by which SNORD114-16 may be a drug target is its role in the regulation of cellular signaling pathways. Studies have shown that SNORD114-16 is involved in the regulation of several cellular signaling pathways, including the regulation of cell growth, cell differentiation, and cell survival. Additionally, studies have shown that SNORD114-16 is involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

SNORD114-16 has also been shown to play a role in the regulation of inflammation. Studies have shown that SNORD114-16 is involved in the regulation of inflammation-related signaling pathways, including the regulation of cytokine production and the regulation of immune cell function.

Potential Biomarker Status

SNORD114-16 has also been identified as a potential biomarker for various diseases. Its unique C/D box structure and its involvement in various cellular processes make it an attractive candidate for use as a biomarker.

One of the potential applications of SNORD114-16 as a biomarker is its ability to be targeted with small molecules. The C/D box region of SNORD114-16 is relatively stable, and this stability

Protein Name: Small Nucleolar RNA, C/D Box 114-16

More Common Targets